263 related articles for article (PubMed ID: 32179557)
1. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8
Jing L; Ott M; Church CD; Kulikauskas RM; Ibrani D; Iyer JG; Afanasiev OK; Colunga A; Cook MM; Xie H; Greninger AL; Paulson KG; Chapuis AG; Bhatia S; Nghiem P; Koelle DM
Cancer Immunol Res; 2020 May; 8(5):648-659. PubMed ID: 32179557
[TBL] [Abstract][Full Text] [Related]
2. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
[TBL] [Abstract][Full Text] [Related]
3. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development.
Tabachnick-Cherny S; Pulliam T; Church C; Koelle DM; Nghiem P
Mol Carcinog; 2020 Jul; 59(7):807-821. PubMed ID: 32219902
[TBL] [Abstract][Full Text] [Related]
4. Human CD4
Longino NV; Yang J; Iyer JG; Ibrani D; Chow IT; Laing KJ; Campbell VL; Paulson KG; Kulikauskas RM; Church CD; James EA; Nghiem P; Kwok WW; Koelle DM
Cancer Immunol Res; 2019 Oct; 7(10):1727-1739. PubMed ID: 31405946
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.
Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
[TBL] [Abstract][Full Text] [Related]
6. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.
Walsh NM; Fleming KE; Hanly JG; Dakin Hache K; Doucette S; Ferrara G; Cerroni L
Hum Pathol; 2016 Jun; 52():190-6. PubMed ID: 26980039
[TBL] [Abstract][Full Text] [Related]
7. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.
Lyngaa R; Pedersen NW; Schrama D; Thrue CA; Ibrani D; Met O; Thor Straten P; Nghiem P; Becker JC; Hadrup SR
Clin Cancer Res; 2014 Apr; 20(7):1768-78. PubMed ID: 24526738
[TBL] [Abstract][Full Text] [Related]
8. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
[TBL] [Abstract][Full Text] [Related]
9. Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
Afanasiev OK; Yelistratova L; Miller N; Nagase K; Paulson K; Iyer JG; Ibrani D; Koelle DM; Nghiem P
Clin Cancer Res; 2013 Oct; 19(19):5351-60. PubMed ID: 23922299
[TBL] [Abstract][Full Text] [Related]
10. Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma.
Samimi M; Benlalam H; Aumond P; Gaboriaud P; Fradin D; Kervarrec T; Florenceau L; Vignard V; Blom A; Touzé A; Gervois N; Labarriere N
Cell Immunol; 2019 Oct; 344():103961. PubMed ID: 31472938
[TBL] [Abstract][Full Text] [Related]
11. Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus.
Gavvovidis I; Leisegang M; Willimsky G; Miller N; Nghiem P; Blankenstein T
Clin Cancer Res; 2018 Aug; 24(15):3644-3655. PubMed ID: 29669806
[No Abstract] [Full Text] [Related]
12. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
Ricci C; Righi A; Ambrosi F; Gibertoni D; Maletta F; Uccella S; Sessa F; Asioli S; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
Endocr Pathol; 2020 Mar; 31(1):21-32. PubMed ID: 31808008
[TBL] [Abstract][Full Text] [Related]
13. Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.
Chapuis AG; Afanasiev OK; Iyer JG; Paulson KG; Parvathaneni U; Hwang JH; Lai I; Roberts IM; Sloan HL; Bhatia S; Shibuya KC; Gooley T; Desmarais C; Koelle DM; Yee C; Nghiem P
Cancer Immunol Res; 2014 Jan; 2(1):27-36. PubMed ID: 24432305
[TBL] [Abstract][Full Text] [Related]
14. Global PD-L1 Signals and Tumor-Infiltrating Lymphocytes: Markers of Immunogenicity in Different Subsets of Merkel Cell Carcinoma and Potential Therapeutic Implications.
Walsh NM; Castonguay MC; Carter MD; Pasternak S; Ly TY; Doucette S; Hanly JG; Saggini A; Cerroni L
Am J Dermatopathol; 2019 Nov; 41(11):819-825. PubMed ID: 31634167
[TBL] [Abstract][Full Text] [Related]
15. LAMP1 targeting of the large T antigen of Merkel cell polyomavirus results in potent CD4 T cell responses and tumor inhibition.
Buchta Rosean C; Leyder EC; Hamilton J; Carter JJ; Galloway DA; Koelle DM; Nghiem P; Heiland T
Front Immunol; 2023; 14():1253568. PubMed ID: 37711623
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
Miller NJ; Church CD; Fling SP; Kulikauskas R; Ramchurren N; Shinohara MM; Kluger HM; Bhatia S; Lundgren L; Cheever MA; Topalian SL; Nghiem P
J Immunother Cancer; 2018 Nov; 6(1):131. PubMed ID: 30482247
[TBL] [Abstract][Full Text] [Related]
17. Polyomavirus-positive Merkel cell carcinoma: the beginning of the beginning.
Wong MK; Yee C
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618960
[TBL] [Abstract][Full Text] [Related]
18. Robust Production of Merkel Cell Polyomavirus Oncogene Specific T Cells From Healthy Donors for Adoptive Transfer.
Davies SI; Barrett J; Wong S; Chang MJ; Muranski PJ; Brownell I
Front Immunol; 2020; 11():592721. PubMed ID: 33362774
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival.
Lipson EJ; Vincent JG; Loyo M; Kagohara LT; Luber BS; Wang H; Xu H; Nayar SK; Wang TS; Sidransky D; Anders RA; Topalian SL; Taube JM
Cancer Immunol Res; 2013 Jul; 1(1):54-63. PubMed ID: 24416729
[TBL] [Abstract][Full Text] [Related]
20. Merkel Cell Carcinomas Arising in Autoimmune Disease Affected Patients Treated with Biologic Drugs, Including Anti-TNF.
Rotondo JC; Bononi I; Puozzo A; Govoni M; Foschi V; Lanza G; Gafà R; Gaboriaud P; Touzé FA; Selvatici R; Martini F; Tognon M
Clin Cancer Res; 2017 Jul; 23(14):3929-3934. PubMed ID: 28174236
[No Abstract] [Full Text] [Related]
[Next] [New Search]
